Insider Trading: AcelRx Pharmaceuticals Inc (ACRX.O)
ACRX.O on Consolidated Issue listed on NASDAQ Global Market
6.68USD
17 May 2013
6.68USD
17 May 2013
Price Change (% chg)
$-0.51 (-7.09%)
$-0.51 (-7.09%)
Prev Close
$7.19
$7.19
Open
$7.26
$7.26
Day's High
$7.26
$7.26
Day's Low
$6.50
$6.50
Volume
337,468
337,468
Avg. Vol
304,068
304,068
52-wk High
$7.30
$7.30
52-wk Low
$2.27
$2.27
DASU BADRI N
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 1 Mar 2013 | Sell | 1,363 | $4.96 | 18,139 |
| 1 Mar 2012 | Sell | 1,511 | $2.91 | 12,006 |
| 1 Sep 2011 | Sell | 1,354 | $3.10 | 13,517 |
Institutional Holders
| % Shares Owned: | 78.56% |
| # of Holders: | 39 |
| Total Shares Held: | 29,254,623 |
| 3 Mo. Net Change: | -1,280,050 |
| # New Positions: | 12 |
| # Closed Positions: | 10 |
| # Increased Positions: | 24 |
| # Reduced Positions: | 16 |
| # Net Buyers: | 8 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Adrian Adams |
62 | 2013 | Independent Chairman of the Board |
Richard King |
48 | 2010 | President, Chief Executive Officer, Director |
James Welch |
55 | 2010 | Chief Financial Officer |
Pamela Palmer |
50 | 2005 | Chief Medical Officer, Director |
Badri Dasu |
49 | 2007 | Chief Engineering Officer |
Lawrence Hamel |
61 | 2006 | Chief Development Officer |
Mark Edwards |
55 | 2011 | Independent Director |
Stephen Hoffman |
58 | 2010 | Independent Director |
Guy Nohra |
52 | 2006 | Independent Director |
Howard Rosen |
54 | 2008 | Independent Director |
Mark Wan |
47 | 2006 | Independent Director |

